Social Profile: CYTK (Cytokinetics)

OlympiaReport via Twitter 10:18 AM  04/24/18 reply  |  re-tweet

Cantor Fitzgerald Analysts Give Cytokinetics $CYTK (Msgs, Twts) a $10.00 Price Target https://t.co/H1jb08jXev

Briefingcom via Twitter 09:37 AM  04/24/18 reply  |  re-tweet

$CYTK (Msgs, Twts): Cytokinetics presents data from the Phase 2 clinical study of reldesemtiv in patients with spinal muscular... https://t.co/jBMhEWpMSY

scrooge_fs via Twitter 07:57 AM  04/24/18 reply  |  re-tweet

Stock $CYTK (Msgs, Twts) has released latest clinical phase report #pennyStocks #stocks #stockMarket #StockTrading #trader #News

stockelite via Twitter 07:41 AM  04/24/18 reply  |  re-tweet

$CYTK (Msgs, Twts) Cytokinetics Announces Presentation of Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spina… https://t.co/urVlL3xejd

portefeuillefun via Twitter 07:35 AM  04/24/18 reply  |  re-tweet

RT @odibro: $CYTK (Msgs, Twts) Presents Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy at the 2018 Annual Cure…

ZoZoStockwatch via Twitter 07:35 AM  04/24/18 reply  |  re-tweet

$CYTK (Msgs, Twts): Cytokinetics Announces Presentation of Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spin… https://t.co/PNzygaTvxK

stocknewsdotcom via Twitter 07:34 AM  04/24/18 reply  |  re-tweet

$CYTK (Msgs, Twts) Presents data from the Phase 2 clinical study of reldesemtiv in patients with spinal muscular atrophy https://t.co/1RbNbZsf69

odibro via Twitter 07:33 AM  04/24/18 reply  |  re-tweet

$CYTK (Msgs, Twts) Presents Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy at the 2018… https://t.co/T4Lpvd894z

Allstocknews via Twitter 07:31 AM  04/24/18 reply  |  re-tweet

$CYTK (Msgs, Twts) Cytokinetics Announces Presentation of Data From Phase 2 Clinical Study of Reldesemtiv in Patients With From our Stock News Alerts App

TickerReport via Twitter 05:42 AM  04/23/18 reply  |  re-tweet

Cytokinetics $CYTK (Msgs, Twts) to Release Quarterly Earnings on Wednesday https://t.co/RMwDvSwGLy

WatchlistN via Twitter 05:41 AM  04/23/18 reply  |  re-tweet

Cytokinetics $CYTK (Msgs, Twts) Scheduled to Post Quarterly Earnings on Wednesday https://t.co/hBVkjTERQn

OlympiaReport via Twitter 03:58 PM  04/22/18 reply  |  re-tweet

Cytokinetics $CYTK (Msgs, Twts) Getting Somewhat Favorable News Coverage, Analysis Finds https://t.co/xAa5X00DyF

dispatchtribune via Twitter 03:57 PM  04/22/18 reply  |  re-tweet

Somewhat Positive Press Coverage Somewhat Unlikely to Impact Cytokinetics $CYTK (Msgs, Twts) Stock Price https://t.co/Xlq9m2Rj4t

WeekHerald via Twitter 03:55 PM  04/22/18 reply  |  re-tweet

Somewhat Positive Press Coverage Somewhat Unlikely to Impact Cytokinetics $CYTK (Msgs, Twts) Stock Price https://t.co/ACj52nKErE

1MinuteStock via Twitter 12:22 PM  04/21/18 reply  |  re-tweet

We calculated 21-day Expected Return of $CYTK (Msgs, Twts) for you: -14.92% https://t.co/ANdISJBylL